rang
implic
pathogen
paediatr
communityacquir
pneumonia
cap
wide
includ
virus
bacteria
coinfect
studi
pneumonia
frequent
report
low
level
pathogen
identif
although
improv
knowledg
pneumonia
aetiolog
essenti
develop
target
manag
effect
public
health
strategi
vaccin
uk
pneumococc
conjug
vaccin
pcv
introduc
routin
septemb
replac
april
vaccin
schedul
three
dose
administ
month
age
first
introduc
year
age
receiv
one
two
dose
respect
part
catchup
programm
children
age
year
identifi
aetiolog
paediatr
cap
challeng
larg
number
potenti
pathogen
may
also
carri
commens
organ
complic
interpret
result
test
nasopharyng
sampl
convent
method
blood
cultur
serolog
often
limit
sensit
due
inadequ
sampl
volum
lack
convalesc
sera
molecular
diagnost
routin
use
assess
viral
respiratori
infect
similar
techniqu
develop
detect
bacteri
respiratori
infect
resti
et
al
demonstr
signific
improv
identif
pneumococc
pneumonia
children
pcr
blood
sampl
appli
simultan
blood
cultur
recent
studi
italian
children
age
year
overal
bacteraem
pneumococc
pneumonia
identifi
establish
pcr
blood
cultur
subject
introduct
pcv
expect
decreas
incid
pneumonia
children
support
regionwid
epidemiolog
prospect
survey
present
data
studi
conduct
two
period
addit
pcv
design
describ
proport
caus
pathogen
paediatr
cap
describ
identif
caus
pathogen
could
improv
applic
pcrbase
assay
diseas
incid
declin
longer
recruit
period
postvaccin
studi
therefor
plan
order
larger
cohort
repres
aetiolog
data
two
prospect
studi
undertaken
august
juli
octob
march
enrol
children
north
east
england
exclud
cumbria
age
year
present
clinic
radiolog
featur
suggest
pneumonia
admit
paediatr
servic
great
north
children
hospit
newcastl
upon
tyne
formerli
newcastl
gener
royal
victoria
infirmari
region
cardiothorac
centr
freeman
hospit
newcastl
upon
tyne
jame
cook
hospit
middlesbrough
cohort
studi
proport
children
pneumonia
seen
recruit
site
part
previous
publish
region
epidemiolog
survey
consent
enrol
aetiolog
studi
extend
panel
investig
written
inform
consent
obtain
parent
assent
obtain
older
children
ethic
approv
grant
newcastl
north
tynesid
research
ethic
committe
research
approv
board
south
tee
hospit
nh
trust
middlesbrough
caldicott
approv
also
obtain
research
team
doctor
nurs
led
ascertain
standardis
diagnosi
pneumonia
recruit
procedur
recruit
methodolog
enrol
criteria
consist
across
two
studi
includ
children
histori
sign
symptom
suggest
lower
respiratori
tract
infect
includ
fever
tachypnoea
defin
agespecif
respiratori
rate
dyspnoea
cough
respiratori
distress
chest
wall
retract
auscultatori
find
crackl
bronchial
breath
reduc
breath
sound
togeth
chest
radiograph
find
consist
pneumonia
determin
initi
local
paediatrician
data
creactiv
protein
full
blood
count
indic
use
clinic
indic
admit
team
inform
diagnosi
pneumonia
exclus
criteria
includ
resid
outsid
north
east
england
clinic
diagnosi
bronchiol
hospitalis
preced
week
normal
chest
radiograph
formal
report
radiologist
chest
radiograph
review
second
consult
radiologist
one
studi
region
centr
newcastl
upon
tyne
blind
clinic
data
first
report
radiolog
find
categoris
lobar
patchi
perihilar
accord
world
health
organ
criteria
pneumococc
conjug
immunis
histori
includ
valenc
pcv
obtain
parent
crosscheck
child
parentheld
health
record
gener
practic
surgeri
contact
clarifi
dose
given
uncertainti
immunis
histori
collect
prevaccin
studi
blood
sampl
collect
serum
blood
cultur
bactalert
craponn
franc
pneumococc
pcr
test
approxim
week
later
blood
collect
convalesc
serolog
parent
often
declin
return
convalesc
sampl
postvaccin
studi
contribut
variabl
number
investig
perform
nasopharyng
secret
includ
aspir
infant
andor
swab
older
children
nasopharyng
aspir
sampl
place
sodium
chlorid
transport
solut
swab
medic
wire
equip
co
ltd
corsham
uk
tracheobronchi
secret
collect
via
endotrach
tube
bronchoalveolar
lavag
pleural
fluid
test
obtain
natur
collect
sampl
standardis
across
age
studi
recoveri
bacteri
pathogen
nasopharyng
secret
sputum
urinari
pneumococc
antigen
consid
evid
definit
infect
due
risk
physiolog
colonis
therefor
posit
result
classifi
like
caus
pathogen
pneumonia
accord
defin
diagnost
criteria
present
discuss
tabl
posit
result
potenti
colonis
abovement
site
ad
togeth
separ
rate
group
among
unknown
caus
figur
reader
inform
test
part
routin
clinic
care
sampl
store
subsequ
analysi
investig
perform
microbiolog
laboratori
newcastl
upon
tyne
hospit
nh
trust
health
protect
agenc
hpa
public
health
laboratori
newcastl
upon
tyne
apart
local
perform
routin
diagnost
test
sampl
middlesbrough
transport
newcastl
upon
tyne
via
daili
transport
servic
pneumococc
isol
blood
respiratori
secret
includ
pleural
fluid
serotyp
multiplex
immunoassay
use
xmap
bead
bioplex
biorad
hercul
ca
usa
detect
serotypespecif
streptococcu
pneumonia
antigen
nation
hpa
respiratori
system
infect
laboratori
london
uk
prevaccin
immunofluoresc
antibodi
test
ifat
appli
respiratori
secret
use
chemicon
temecula
ca
usa
simufluor
fluorescein
isothiocyan
respiratori
syncyti
viru
rsv
influenza
b
parainfluenza
adenoviru
human
metapneumoviru
hmpv
test
use
ifat
utilis
inhous
pool
antihmpv
monoclon
antibodi
viral
screen
perform
postvaccin
studi
use
inhous
multiplex
realtim
pcr
assay
target
panel
expand
includ
pandem
influenza
subtyp
parainfluenza
viru
rhinoviru
coronaviru
bocaviru
plu
virus
previous
test
ifat
viral
serolog
test
includ
rsv
influenza
b
adenoviru
total
nucleic
acid
extract
blood
sampl
studi
test
use
pneumoniaespecif
pcr
assay
target
pneumolysin
gene
acut
complement
fixat
test
antibodi
screen
atyp
bacteria
respiratori
virus
also
perform
includ
mycoplasma
igm
antibodi
pneumonia
chlamydia
pneumonia
c
psittaci
well
coxiella
burnetii
legionella
pneumophila
serogroup
postvaccin
studi
antistreptolysin
titr
assay
studi
use
rheumajet
aso
kit
launch
diagnost
longfield
uk
data
analys
use
epi
infotm
center
diseas
control
prevent
atlanta
ga
usa
summari
isol
pathogen
present
frequenc
categoris
viral
bacteri
mix
infect
detect
rate
pathogen
express
proport
test
result
compar
relat
age
group
age
group
classif
year
start
postvaccin
studi
children
year
age
group
vaccin
pcv
would
allow
investig
rel
contribut
pneumococc
infect
caus
pneumonia
well
role
pathogen
common
methodolog
diagnosi
studi
identif
rate
infect
compar
use
fisher
exact
test
odd
ratio
confid
interv
subgroup
analysi
within
postvaccin
studi
perform
children
enrol
introduc
april
compar
rate
infect
group
relat
data
prevaccin
studi
postvaccin
studi
octob
march
tabl
show
number
pathogen
identifi
agegroup
distribut
viral
mix
infect
significantli
higher
postvaccin
prevaccin
respect
detect
virus
use
combin
pcr
serolog
assay
postvaccin
higher
achiev
test
immunofluoresc
serolog
prevaccin
improv
viral
detect
thought
due
applic
pcr
assay
replac
immunofluoresc
test
respiratori
secret
postvaccin
acut
viral
serolog
assay
posit
seven
patient
influenza
viru
infect
wherea
prevaccin
combin
acut
convalesc
serolog
identifi
eight
patient
rsv
infect
eight
patient
adenoviru
four
influenza
ab
virus
one
viru
postvaccin
rsv
detect
sampl
type
rhinoviru
influenza
adenovirus
figur
compar
prevaccin
adenoviru
influenza
ab
higher
rsv
identifi
caus
pathogen
postvaccin
virus
detect
among
age
year
compar
find
prevaccin
studi
hmpv
detect
prevaccin
respiratori
sampl
test
identifi
one
child
postvaccin
studi
differ
rate
bacteri
infect
postvaccin
total
compar
prevaccin
overal
identifi
pneumococc
infect
differ
studi
repres
among
children
test
postvaccin
age
year
year
respect
compar
prevaccin
seven
among
age
year
year
respect
postvaccin
studi
diagnosi
pneumococc
infect
improv
pcr
use
compar
cultur
eight
serotyp
identifi
postvaccin
studi
serotyp
rate
posit
blood
cultur
postvaccin
almost
doubl
prevaccin
group
streptococc
infect
confirm
greater
proport
children
postvaccin
prevaccin
group
infect
associ
sever
diseas
twothird
case
empyema
pneumonia
identifi
acut
serolog
children
postvaccin
two
age
year
six
patient
age
year
rate
detect
mycoplasma
infect
higher
prevaccin
pair
acut
convalesc
sampl
avail
nine
age
year
age
year
among
children
enrol
period
caus
pathogen
identifi
pneumonia
identifi
compar
first
year
vaccin
rate
infect
bacteri
viral
mix
rate
bacteri
infect
similar
figur
pre
entir
postvaccin
studi
differ
rate
viral
infect
introduct
postvaccin
studi
first
publish
studi
describ
aetiolog
cap
uk
children
prior
follow
introduct
time
comprehens
studi
year
introduct
first
year
provid
baselin
futur
compar
studi
pneumonia
aetiolog
set
caus
pathogen
identifi
predomin
virus
studi
detect
pneumococc
infect
increas
preto
postvaccin
studi
presum
consequ
applic
molecular
diagnost
method
previou
uk
studi
investig
aetiolog
pneumonia
prior
introduct
abl
identifi
caus
pathogen
children
addit
blood
cultur
blood
test
pneumonia
mycoplasma
chlamydia
use
pcr
identifi
children
pneumococc
pneumonia
anoth
studi
identifi
pneumococc
infect
use
pneumolysin
elisa
blood
identif
rate
like
caus
pathogen
postvaccin
studi
similar
report
et
al
use
serolog
assay
howev
lower
detect
rate
studi
use
serolog
andor
molecular
approach
higher
rate
previous
found
prior
introduct
conjug
vaccin
improv
detect
rate
two
studi
appear
relat
differ
laboratori
approach
use
molecular
diagnost
method
improv
respiratori
viru
detect
bacteri
detect
normal
steril
site
interpret
result
problemat
appli
nasopharyng
secret
respiratori
sampl
addit
pneumococc
pneumolysin
dna
detect
blood
healthi
children
colonis
pneumococcu
pneumolysin
gene
also
detect
nonpneumococc
viridansgroup
streptococci
particularli
pseudopneumonia
miti
potenti
confound
result
use
pneumolysin
pcr
studi
therefor
includ
fals
posit
associ
pneumococc
carriag
crossreact
viridansgroup
streptococci
given
low
pneumococc
carriag
rate
popul
former
unlik
although
well
explor
viral
carriag
also
clinic
possibl
lead
posit
pcr
result
necessarili
correl
observ
pneumonia
henc
result
pcrbase
approach
limit
make
definit
diagnosi
caus
pathogen
pneumonia
rate
pneumococc
infect
two
dataset
lower
studi
countri
higher
previous
describ
uk
improv
pneumococc
identif
applic
pcr
compar
cultur
alon
consist
previou
studi
similar
report
increas
recent
italian
studi
interest
despit
overal
decreas
incid
hospitalis
pneumonia
sinc
introduct
rate
pneumococc
infect
compar
two
studi
replac
serotyp
caus
invas
pneumococc
diseas
well
recognis
may
explain
find
face
reduct
diseas
incid
pneumococc
serotyp
possibl
major
identifi
pleural
fluid
serotyp
recov
includ
similar
data
usa
children
empyema
serotyp
primarili
similar
serotyp
studi
despit
lack
comprehens
serotyp
data
suggest
could
substanti
reduc
invas
pneumococc
diseas
serolog
evid
mycoplasma
infect
detect
children
pre
postvaccin
studi
respect
rate
similar
publish
literatur
pneumonia
tradit
consid
pathogen
older
children
studi
identifi
frequent
year
age
serolog
evid
atyp
organ
identifi
although
may
consequ
lack
convalesc
sera
aureu
group
streptococc
infect
often
associ
sever
pneumonia
empyema
keep
previou
find
group
streptococcu
found
children
pneumonia
compar
respect
pre
postvaccin
dataset
introduct
pcv
decreas
pneumococc
pneumonia
possibl
rel
proport
bacteria
group
streptococcu
aureu
well
pneumonia
caus
sever
pneumonia
increas
virus
either
alon
copathogen
detect
children
pre
postvaccin
studi
respect
rsv
commonli
detect
pathogen
previous
report
follow
rhinoviru
influenza
adenoviru
similar
data
previous
describ
region
diagnosi
viral
infect
achiev
mainli
test
respiratori
secret
rather
serolog
posit
seven
children
influenza
viru
improv
detect
virus
postvaccin
studi
mainli
achiev
applic
pcr
assay
respiratori
viral
screen
virus
detect
identifi
age
year
consist
studi
postvaccin
studi
viral
screen
expand
includ
eight
virus
subgroup
includ
pandem
delin
contribut
caus
cap
children
uk
consid
time
second
recruit
period
pandem
influenza
singl
pathogen
implic
mani
case
pneumonia
low
isol
rate
bocaviru
coronaviru
hmpv
highlight
minim
contribut
virus
aetiolog
pneumonia
children
uk
rate
mix
infect
variabl
two
studi
like
depend
screen
method
use
identifi
caus
pathogen
sever
limit
data
potenti
season
bia
data
postvaccin
studi
recruit
carri
month
includ
two
winter
season
enrol
children
although
postvaccin
studi
cover
two
winter
season
number
children
enrol
fewer
prevaccin
studi
could
true
reflect
decreas
diseas
incid
hospitalis
find
postvaccin
studi
may
hamper
lack
convalesc
sera
may
led
underestim
role
atyp
bacteria
paediatr
pneumonia
effect
probabl
minim
mycoplasma
infect
detect
three
children
pair
serum
sampl
prevaccin
studi
lack
serotyp
data
identifi
pneumococci
prevaccin
studi
limit
true
comparison
serotyp
profil
implement
conjug
vaccin
anoth
limit
variat
two
studi
diagnost
method
use
pathogen
investig
make
interpret
compar
find
guard
signific
improv
pathogen
identif
applic
pcr
assay
add
evid
import
use
techniqu
monitor
chang
epidemiolog
paediatr
cap
pneumococc
serotyp
replac
conclus
although
virus
common
caus
pneumonia
around
fifth
children
bacteri
infect
combin
use
cultur
serolog
pcrbase
diagnost
test
significantli
improv
identif
caus
pathogen
paediatr
cap
replac
like
associ
signific
reduct
pneumococc
diseas
serotyp
predomin
requir
continu
surveil
monitor
emerg
serotyp
replac
